OxyContin maker admits to actions aimed at boosting opioid prescriptions, including conspiring to defraud officials and offering illegal kickbacks
Purdue Pharma pleaded guilty to criminal charges over the handling of its addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker’s role in the US opioid crisis.
During a court hearing conducted remotely on Tuesday before US district judge Madeline Cox Arleo in New Jersey, Purdue pleaded guilty to three felonies covering widespread misconduct.
